Daniel Kermany

6.6k total citations · 1 hit paper
8 papers, 641 citations indexed

About

Daniel Kermany is a scholar working on Molecular Biology, Surgery and Ophthalmology. According to data from OpenAlex, Daniel Kermany has authored 8 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Ophthalmology. Recurrent topics in Daniel Kermany's work include Optical Coherence Tomography Applications (2 papers), Coronary Interventions and Diagnostics (2 papers) and Retinal Diseases and Treatments (2 papers). Daniel Kermany is often cited by papers focused on Optical Coherence Tomography Applications (2 papers), Coronary Interventions and Diagnostics (2 papers) and Retinal Diseases and Treatments (2 papers). Daniel Kermany collaborates with scholars based in United States, China and Sweden. Daniel Kermany's co-authors include Kang Zhang, Michael Singer, Sepehr Bahadorani, Charlotte L Zhang, Fei Li, Xiulan Zhang, Shida Chen, Xiaodong Sun, Yayi Wang and Xin Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical ophthalmology and Cancer Communications.

In The Last Decade

Daniel Kermany

8 papers receiving 607 citations

Hit Papers

Labeled Optical Coherence Tomography (OCT) and Chest X-Ra... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Kermany United States 5 514 343 137 86 84 8 641
Yangqin Feng Singapore 12 258 0.5× 232 0.7× 165 1.2× 68 0.8× 22 0.3× 20 444
Mingquan Lin United States 11 163 0.3× 117 0.3× 102 0.7× 41 0.5× 53 0.6× 48 397
Joaquim de Moura Spain 14 506 1.0× 149 0.4× 88 0.6× 249 2.9× 37 0.4× 68 604
Ahmed Sharafeldeen United States 13 366 0.7× 85 0.2× 58 0.4× 157 1.8× 37 0.4× 27 411
Khin Yadanar Win Thailand 11 223 0.4× 120 0.3× 174 1.3× 107 1.2× 23 0.3× 16 354
Abolfazl Zargari Khuzani United States 6 400 0.8× 296 0.9× 95 0.7× 6 0.1× 67 0.8× 13 503
Aaron Loh United States 3 189 0.4× 227 0.7× 86 0.6× 10 0.1× 32 0.4× 3 375
Ali Serener Cyprus 12 361 0.7× 134 0.4× 140 1.0× 175 2.0× 47 0.6× 31 489
Bejoy Abraham India 9 295 0.6× 233 0.7× 96 0.7× 6 0.1× 98 1.2× 17 417

Countries citing papers authored by Daniel Kermany

Since Specialization
Citations

This map shows the geographic impact of Daniel Kermany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kermany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kermany more than expected).

Fields of papers citing papers by Daniel Kermany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kermany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kermany. The network helps show where Daniel Kermany may publish in the future.

Co-authorship network of co-authors of Daniel Kermany

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kermany. A scholar is included among the top collaborators of Daniel Kermany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kermany. Daniel Kermany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kermany, Daniel, Weijie Zhang, Lin Wang, et al.. (2025). Multiscale 3D spatial analysis of the tumor microenvironment using whole‐tissue digital histopathology. Cancer Communications. 45(3). 386–390. 1 indexed citations
2.
Chen, Shida, Yayi Wang, Yaoming Liu, et al.. (2022). Dysbiosis of gut microbiome contributes to glaucoma pathogenesis. SHILAP Revista de lepidopterología. 1(2). 18 indexed citations
3.
Chu, Edward R., Sepehr Bahadorani, Daniel Kermany, et al.. (2019). <p>The effects of temporary intraocular pressure spikes after intravitreal dexamethasone implantation on the retinal nerve fiber layer</p>. Clinical ophthalmology. Volume 13. 1079–1086. 4 indexed citations
4.
Kermany, Daniel. (2018). Large Dataset of Labeled Optical Coherence Tomography (OCT) and Chest X-Ray Images. Data Archiving and Networked Services (DANS). 3. 113 indexed citations
5.
Kermany, Daniel. (2018). Labeled Optical Coherence Tomography (OCT) and Chest X-Ray Images for Classification. Data Archiving and Networked Services (DANS). 2. 472 indexed citations breakdown →
6.
Kermany, Daniel, et al.. (2018). Appointment Compliance in Patients With Diabetic Macular Edema and Exudative Macular Degeneration. Ophthalmic surgery, lasers & imaging retina. 49(3). 186–190. 22 indexed citations
7.
Fu, Xin, Viet Anh Nguyen Huu, Yaou Duan, et al.. (2018). Clinical applications of retinal gene therapies. Precision Clinical Medicine. 1(1). 5–20. 10 indexed citations
8.
Kermany, Daniel. (2017). Labeled Optical Coherence Tomography (OCT) for Classification. Data Archiving and Networked Services (DANS). 1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026